ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,409.17
-2.46%
S&P 500
5,269.57
-0.71%
Dow Jones
39,066.07
-1.52%
US Dollar vs Yen
156.931
0.14%
Brent Oil
81.11
-0.52%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cytek Biosciences Inc (CTKB)

  7. Cytek Biosciences Inc (CTKB) ニュース

CTKB

Cytek Biosciences (CTKB)

Cytek Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CTKB
日付受信時刻ニュースソース見出しコード企業名
2024/05/2307 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2106 : 30GlobeNewswire Inc.Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis SystemsNASDAQ:CTKBCytek Biosciences Inc
2024/05/0905 : 35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTKBCytek Biosciences Inc
2024/05/0905 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
2024/05/0905 : 05GlobeNewswire Inc.Cytek Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
2024/05/0106 : 30GlobeNewswire Inc.Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and EuropeNASDAQ:CTKBCytek Biosciences Inc
2024/04/2922 : 00GlobeNewswire Inc.Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:CTKBCytek Biosciences Inc
2024/03/1921 : 00GlobeNewswire Inc.Cytek® Biosciences Names William McCombe Chief Financial OfficerNASDAQ:CTKBCytek Biosciences Inc
2024/03/0908 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/03/0908 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/03/0908 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/03/0908 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/03/0908 : 44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/03/0807 : 30GlobeNewswire Inc.Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis SolutionsNASDAQ:CTKBCytek Biosciences Inc
2024/03/0120 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
2024/02/2907 : 05GlobeNewswire Inc.Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookNASDAQ:CTKBCytek Biosciences Inc
2024/02/2720 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
2024/02/2307 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/02/2307 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/02/2307 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/02/2307 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/02/2307 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/02/2307 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/02/1506 : 07Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CTKBCytek Biosciences Inc
2024/02/0806 : 10GlobeNewswire Inc.Cytek Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CTKBCytek Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CTKB

最近閲覧した銘柄

NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
USOTC
BASFY
BASF (QX)
USOTC
RHHBY
Roche (QX)
FX
USDEUR
US Dollar vs Euro
USI
USTECH100
US Tech 100
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
FX
USDGBP
US Dollar vs Sterling
NYSE
NKE
Nike
AMEX
XLV
Health Care Select Sector
CCOM
SILVER
SILVER
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有